1st Series on EOL (End of life) Care discussion – Think philosophy of life and death
date : 6/28/2013
Japan will experience an aging society by 2035 as one in three people in Japan will be over the age of 65. Japan will be the first country in human history to experience such a phenomenon, hence, it is Japan’s duty to ask questions; “How to Age and How to Die” and “The Ideal Ways of End of Life Care .” The aging issue has been known as a forbidden topic that cannot be discussed in the public but it is time to change. In the light of this, this consecutive seminar will aim to hold a discussion that allows young professionals from economic, medical, academic, media, legislative and administrative sectors to suggest action plans.
1st Series on EOL (End of life) Care discussion – Think philosophy of life and death
The discussion will investigate the issues surrounding end of life care to examine comprehensive points of view. This allows multispectral speakers to exchange their opinions in order to share the points at the issue with citizens.
Data: July 2nd (Tuesday) 19:00-21:00
Place: Tokyo 21c club (Shin-Marunouchi Build. 10F 1-5-1Marunouchi, Chiyoda-ku, Tokyo)
Organized by: Health and Global Policy Institution, NPO
Points of view: It allows multispectral speakers to exchange their opinions.
Targeted audience: Legislative body, Companies, Universities, Citizens, Mayor, Media (Reservation only)
Language: Japanese (No interpretation)
Program：
１. Discussion Point of EOL Care (Mr. Kazuhisa Takeuchi (McKinsey and Company ))
2. Philosophy of Life/Death and Community （Speaker：Yoshinori Hiroi (Professor at Chiba University, School of Law）
3. Interactive Discussion with Panelist (Seminar Proposers)
【Seminar Proposers】 （Syllabary order, Titles omitted）
– Mr. Daisuke Iwase President, Lifenet Insurance Company
– Mr. Kohei Onozaki Vice President, Corporate Affairs AstraZeneca K.K.
– Mr. Ken Shibusawa Board Chairman, Japan Center for International Exchange/ CEO of Commons Asset Management
– Mr. Kazuhisa Takeuchi McKinsey and Company
– Mr. Toshio Miyata Deputy Director of Office, Minister of Health, Labour and Welfare/ Surgeon
1st Series on EOL (End of life) Care discussion – Think philosophy of life and death
The discussion will investigate the issues surrounding end of life care to examine comprehensive points of view. This allows multispectral speakers to exchange their opinions in order to share the points at the issue with citizens.
Data: July 2nd (Tuesday) 19:00-21:00
Place: Tokyo 21c club (Shin-Marunouchi Build. 10F 1-5-1Marunouchi, Chiyoda-ku, Tokyo)
Organized by: Health and Global Policy Institution, NPO
Points of view: It allows multispectral speakers to exchange their opinions.
Targeted audience: Legislative body, Companies, Universities, Citizens, Mayor, Media (Reservation only)
Language: Japanese (No interpretation)
Program：
１. Discussion Point of EOL Care (Mr. Kazuhisa Takeuchi (McKinsey and Company ))
2. Philosophy of Life/Death and Community （Speaker：Yoshinori Hiroi (Professor at Chiba University, School of Law）
3. Interactive Discussion with Panelist (Seminar Proposers)
【Seminar Proposers】 （Syllabary order, Titles omitted）
– Mr. Daisuke Iwase President, Lifenet Insurance Company
– Mr. Kohei Onozaki Vice President, Corporate Affairs AstraZeneca K.K.
– Mr. Ken Shibusawa Board Chairman, Japan Center for International Exchange/ CEO of Commons Asset Management
– Mr. Kazuhisa Takeuchi McKinsey and Company
– Mr. Toshio Miyata Deputy Director of Office, Minister of Health, Labour and Welfare/ Surgeon
Exhibition date：2013-07-02
Top Research & Recommendations Posts
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] The Path to a Sustainable Healthcare System: Three Key Objectives for Public Deliberation (January 22, 2026)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Recommendations] “Balancing Sustainability and Innovation in the Healthcare System” (December 26, 2025)
- [Publication Report] Planetary Health Promotion Project “Issues Facing Planetary Health and the Role of the Health Sector” (May 10, 2023)
Featured Posts
-
2026-01-09
[Registration Open] (Hybrid Format) Dementia Project FY2025 Initiative Concluding Symposium “The Future of Dementia Policy Surrounding Families and Others Who Care for People with Dementia” (March 9, 2026)
![[Registration Open] (Hybrid Format) Dementia Project FY2025 Initiative Concluding Symposium “The Future of Dementia Policy Surrounding Families and Others Who Care for People with Dementia” (March 9, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/dementia-20260309-top.png)
-
2026-01-22
[Policy Recommendations] The Path to a Sustainable Healthcare System: Three Key Objectives for Public Deliberation (January 22, 2026)
![[Policy Recommendations] The Path to a Sustainable Healthcare System: Three Key Objectives for Public Deliberation (January 22, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/is-20260122-top_ENG.png)
-
2026-01-26
[HGPI Policy Column] (No.68) – From the Intractable and Rare Diseases Project “Part 2 – Making Intractable and Rare Diseases a Priority Issue for the International Community: The WHA Resolution’s Vision for a Global Action Plan and Japan’s Role”
![[HGPI Policy Column] (No.68) – From the Intractable and Rare Diseases Project “Part 2 – Making Intractable and Rare Diseases a Priority Issue for the International Community: The WHA Resolution’s Vision for a Global Action Plan and Japan’s Role”](https://hgpi.org/en/wp-content/uploads/sites/2/Eyecatch_Column_RD_2-1.png)
-
2026-01-26
[Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
![[Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)](https://hgpi.org/en/wp-content/uploads/sites/2/vc-20250425-top.jpg)
